Clinical trial · Observational

Measuring Surgical Recovery After Radical Cystectomy

NCT03193970CI-TRIAL-00122870recruitingClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Bladder Cancer	Malignant Bladder Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
Post-Operative Recovery Registry	Behavioral	—	UNRESOLVED

Design

Arms and outcomes

Arms (1)

label
Bladder Cancer Patients Undergoing Radical Cystectomy
description
Prospective registry of bladder cancer patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating centers.
interventionNames
1. Behavioral: Post-Operative Recovery Registry

Primary outcomes (1)

measure
Post-Surgical Outcomes in Patients Undergoing Radical Cystectomy
timeFrame
3 months
description
Post-surgical outcomes determined from patient-reported assessment of symptom burden using the MD Anderson Symptom Inventory (MDASI-BLC form).

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

1\. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.

Exclusion Criteria:

N/A

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Apr 30, 2015
Primary completion: Dec 31, 2034
Completion: Dec 31, 2034
First posted: Jun 21, 2017
Last update posted: Aug 19, 2026
Enrollment: 2,000 (estimated)
Lead sponsor: M.D. Anderson Cancer Center OTHER
Keywords: Bladder Cancer, Registry, Post-surgical outcomes, Radical cystectomy, MD Anderson Symptom inventory, MDASI

Data updated 22 days agoSource updated Aug 19, 2026source: clinicaltrials

Locations

Locations by country (10)

Country	Sites	Recruiting
United States	10	7

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.